Literature DB >> 13108703

Evaluation of endocrine therapy for advanced breast cancer.

O H PEARSON, C D WEST, V P HOLLANDER, N E TREVES.   

Abstract

Entities:  

Keywords:  BONES/neoplasms; BREAST/neoplasms; CALCIUM/in urine; HORMONES/therapeutic use; URINE

Mesh:

Substances:

Year:  1954        PMID: 13108703     DOI: 10.1001/jama.1954.02940370046013

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN: 0002-9955


× No keyword cloud information.
  12 in total

Review 1.  HYPERCALCAEMIA AND CANCER.

Authors:  L WATSON
Journal:  Postgrad Med J       Date:  1963-11       Impact factor: 2.401

2.  The clinical features of hypercalcemia associated with malignant disease.

Authors:  O H WARWICK; E R YENDT; J S OLIN
Journal:  Can Med Assoc J       Date:  1961-09-23       Impact factor: 8.262

3.  General medical aspects of malignant disease.

Authors:  J Q MATTHIAS
Journal:  Postgrad Med J       Date:  1961-06       Impact factor: 2.401

4.  [Present status of chemotherapy in human neoplastic diseases].

Authors:  J PIRWITZ
Journal:  Klin Wochenschr       Date:  1957-05-01

5.  The chemical control of cancer.

Authors:  J F HOLLAND
Journal:  Public Health Rep       Date:  1954-12       Impact factor: 2.792

6.  Characteristics of adrenal-dependent mammary cancers.

Authors:  C HUGGINS; T L-Y DAO
Journal:  Ann Surg       Date:  1954-10       Impact factor: 12.969

7.  The care of oral contraceptive users by general practitioners in Oxfordshire.

Authors:  B Johnson; M Thorogood
Journal:  J R Coll Gen Pract       Date:  1977-06

Review 8.  Hormones and neoplasia.

Authors:  A P Forrest
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

9.  Tamoxifen-induced hypercalcaemia and response to treatment.

Authors:  M J Minton; G Sparrow; R D Rubens; J L Hayward
Journal:  Br Med J       Date:  1980-01-19

10.  Adrenalectomy for control of cancer of the breast.

Authors:  N FRIEDMAN; H L JAFFE; M H RABWIN; D H ROSENBLUM; B SIMKIN
Journal:  Calif Med       Date:  1956-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.